Published in Stem Cells Int on July 16, 2017
Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol (1977) 6.82
Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol (2006) 4.71
Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med (2005) 3.43
Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun (2007) 2.67
Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell (2007) 2.47
Aplastic anemia. Curr Opin Hematol (2008) 2.17
Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells (2006) 2.15
NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res (2001) 1.76
P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood (1996) 1.69
An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood (1974) 1.65
Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal (2001) 1.50
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol (1991) 1.48
Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med (1995) 1.33
HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood (2008) 1.33
Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today (1999) 1.30
PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity (1999) 1.27
Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci (2010) 1.23
Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood (2000) 1.18
Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol (2000) 1.18
Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res (2002) 1.15
Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity. Mol Vis (2004) 1.09
Hypoxia. 5. Hypoxia and hematopoiesis. Am J Physiol Cell Physiol (2011) 1.07
Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med (Maywood) (2008) 1.05
Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat Res (2004) 1.01
Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol (1997) 0.95
NF-κB subunit specificity in hemopoiesis. Immunol Rev (2012) 0.95
Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost (1997) 0.94
Adhesion receptors on haematopoietic progenitor cells. Br J Haematol (2001) 0.91
CD164--a novel sialomucin on CD34+ cells. Leuk Lymphoma (2000) 0.88
Chronic intermittent hypobaric hypoxia decreases beta-adrenoceptor activity in right ventricular papillary muscle. Am J Physiol Heart Circ Physiol (2010) 0.83
Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse. Int J Exp Pathol (2006) 0.83
The protective effects of chronic intermittent hypobaric hypoxia pretreatment against collagen-induced arthritis in rats. J Inflamm (Lond) (2015) 0.81
Enhancement of Na/K pump activity by chronic intermittent hypobaric hypoxia protected against reperfusion injury. Am J Physiol Heart Circ Physiol (2011) 0.81
Induction of hypoxia-inducible factor-1alpha and activation of caspase-3 in hypoxia-reoxygenated bone marrow stroma is negatively regulated by the delayed production of substance P. J Immunol (2001) 0.80
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis. Tissue Antigens (2005) 0.80
[The cardioprotection of intermittent hypoxic adaptation]. Sheng Li Xue Bao (2007) 0.79
Busulphan aplasia in rabbits: a model for human aplastic anaemia. Br J Haematol (1982) 0.79
Hematopoietic stem cell transplantation for acquired aplastic anemia. Curr Opin Hematol (2016) 0.78
Chronic intermittent hypobaric hypoxia antagonizes renal vascular hypertension by enhancement of vasorelaxation via activating BKCa. Life Sci (2016) 0.78
Intermittent hypoxia exposure in a hypobaric chamber and erythropoietin abuse interpretation. J Sports Sci (2007) 0.78
Anti-diabetes effect of chronic intermittent hypobaric hypoxia through improving liver insulin resistance in diabetic rats. Life Sci (2016) 0.78
Protection of chronic intermittent hypobaric hypoxia against collagen-induced arthritis in rat through increasing apoptosis. Sheng Li Xue Bao (2011) 0.77
Stroma-dependent maintenance of cytokine responsive hematopoietic progenitor cells derived from long-term bone marrow culture. Cell Struct Funct (2000) 0.77
[A case of severe aplastic anemia having T lymphocytes which suppressed both CFU-E colony formation and immunoglobulin production in vitro (author's transl)]. Rinsho Ketsueki (1981) 0.76
In vitro growth of rat bone marrow BFU-E. Exp Hematol (1989) 0.76
Chronic intermittent hypobaric hypoxia ameliorates diabetic nephropathy through enhancing HIF1 signaling in rats. Diabetes Res Clin Pract (2016) 0.76
Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome. Acta Haematol (2000) 0.76
Novel three-dimensional long-term bone marrow culture system using polymer particles with grafted epoxy-polymer-chains supports the proliferation and differentiation of hematopoietic stem cells. Exp Biol Med (Maywood) (2011) 0.76
Effect of FK-506 and cyclosporin A on in vitro CFU-GM growth in severe aplastic anemia patients. Haematologica (1992) 0.76
Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol (1994) 0.76
Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy. Ann Hematol (1993) 0.76
Effects of chronic intermittent hypobaric hypoxia on the L-type calcium current in rat ventricular myocytes. High Alt Med Biol (2010) 0.75
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy. Stem Cells Int (2015) 0.86
Fas ligand DNA enhances a vaccination effect by coadministered DNA encoding a tumor antigen through augmenting production of antibody against the tumor antigen. J Immunol Res (2015) 0.78
The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease. Biomed Res Int (2016) 0.75